Methods in the Economic Evaluation of Healthcare Interventions

Methods in the Economic Evaluation of Healthcare Interventions

In this group: 202 papers · 97 members

Mendeley

Economics

Groups

Group activity

New updates

Beate Sander added a document to this group

Anatomy of a decision.

23rd April

Beate Sander added a document to this group

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

27th March

Beate Sander added documents to this group

Methods for the Estimation of the NICE Cost Effectiveness Threshold

Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4.

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.

1st February

Brian Chun-Fai Chan

Brian Chun-Fai Chan added a document to this group

Financial impact of improved pressure ulcer staging in the acute hospital with use of a new tool, the NE1 Wound Assessment Tool.

13th August, 2012

Murray Krahn added documents to this group

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

Ontario's formulary committee: how recommendations are made

A clinician's guide to cost-effectiveness analysis

The Stroke Prevention Policy Model: linking evidence and clinical decisions.

A utility approach to the assessment of health-related quality of life.

16th April, 2012

Beate Sander added a document to this group

STATISTICAL METHODS FOR COST-EFFECTIVENESS ANALYSES THAT USE OBSERVATIONAL DATA: A CRITICAL APPRAISAL TOOL AND REVIEW OF CURRENT PRACTICE.

29th March, 2012

Beate Sander added a document to this group

LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS?

27th March, 2012

Murray Krahn added documents to this group

Healthcare costs associated with prostate cancer: estimates from a population-based study.

Health care costs associated with hepatitis C: a longitudinal cohort study.

3rd February, 2012

Beate Sander added documents to this group

Half standard deviation estimate of the minimally important difference in HRQOL scores?

The Minimally Clinically Important Difference in Generic Utility-Based Measures

Divide et impera: protecting the growth of health care incomes (COSTS)

8th December, 2011

Beate Sander added documents to this group

A concise equation that captures the essential elements of one-way sensitivity analyses in health economic models.

Bayesian calibration of a natural history model with application to a population model for colorectal cancer.

Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.

Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus.

Bayesian inference for comorbid disease risks using marginal disease risks and correlation information from a separate source.

7th October, 2011

Claudia Pereira

Claudia Pereira added a document to this group

Health Technology Evaluation of Devices and Drugs : Are There Differences ? Acknowledgments and Disclaimer

26th August, 2011

Murray Krahn added documents to this group

Toward an operational definition of health

A utility maximization model for evaluation of health care programs

On the social rate of discount

The social rate of discount and the optimal rate of investment

The theory of decision making

8th June, 2011

Murray Krahn added documents to this group

Paradigms in the social sciences

The structure of scientific revolutions

19th April, 2011

Beate Sander added documents to this group

Descriptive validity of alternative intertemporal models for health outcomes: an axiomatic test

Toward a more universal approach in health valuation

What happens to value of information measures as the number of decision options increases ?

8th April, 2011

Murray Krahn added documents to this group

The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study

On the use of survival analysis techniques to estimate medical care costs

Estimating health care costs related to cancer treatment from SEER-Medicare data

Evaluation of trends in the cost of initial cancer treatment

Projections of the costs associated with colorectal cancer care in the United States, 2000-2020

24th March, 2011

Murray Krahn added documents to this group

When is evidence sufficient?

EBM, HTA, and CER: clearing the confusion.

Accounting for future costs in medical cost-effectiveness analysis

Bias in published cost effectiveness studies: systematic review

Measuring costs in cost-utility analyses. Variations in the literature

18th March, 2011

Beate Sander added documents to this group

Utility measurement in healthcare: the things I never got to.

Methodology for Measuring Health-State Preferences - II: Scaling Methods.

Relationship between psychometric and quality of life

The Effect of Search Procedures on Utility Elicitations

Valuing health states: A Comparison of methods

16th March, 2011

Murray Krahn added documents to this group

Foundations of cost-effectiveness analysis for health and medical practices

Empirically calibrated model of hepatitis C virus infection in the United States

Utility functions for life years and health status

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

16th March, 2011

Beate Sander likes this.

Beate Sander added documents to this group

A note on QALYs versus HYEs. Health states versus health profiles.

Sensitivity and perspective in the valuation of health status: whose values count?

Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis

A taxonomy of health utility assessment methods and the role for uncertainty analysis.

NICE: faster access to modern treatments? Analysis of guidance on health technologies

11th March, 2011

Beate Sander added documents to this group

Primer on medical decision analysis: Part 1-Getting Started

Primer on medical decision analysis: Part 2-Building a tree.

Primer on medical decision analysis: Part 3-Estimating probabilities and utilities.

Primer on medical decision analysis: Part 4-Analyzing the model and interpreting the results.

Primer on medical decision analysis: Part 5-Working with Markov processes.

9th March, 2011

Load More

About this group

Owned by Beate Sander

Ph.D. Student

Economics

This group is hosted by THETA (Toronto Health Economics and Technology Assessment Collaborative) to collect articles related to methods research on topics of interest in the economic evaluation of healthcare interventions. There are currently four topics: modelling, health economics, preference-based methods, and use of administrative databases for economic evaluation.

120 members

Vladica Velickovic

Dr Ashwini Pratap

administrative databases cost-effectiveness analysis decision analysis economic evaluation economics health health care health economics health policy medicine modelling preference-based methods public health

Follow this group

Join this group

Ask to join this group

Start using Mendeley in seconds!